Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
200
-
Total 13F shares, excl. options
-
15.1M
-
Shares change
-
+1.03M
-
Total reported value, excl. options
-
$963M
-
Value change
-
+$64.7M
-
Put/Call ratio
-
0.32
-
Number of buys
-
102
-
Number of sells
-
-87
-
Price
-
$63.68
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q2 2024
232 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q2 2024.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 200 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.1M shares
of 22.3M outstanding shares and own 67.89% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.66M shares), VANGUARD GROUP INC (1.44M shares), STATE STREET CORP (645K shares), DIMENSIONAL FUND ADVISORS LP (630K shares), Rubric Capital Management LP (604K shares), Global Alpha Capital Management Ltd. (527K shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (489K shares), Deep Track Capital, LP (466K shares), TANG CAPITAL MANAGEMENT LLC (450K shares), and GEODE CAPITAL MANAGEMENT, LLC (408K shares).
This table shows the top 200 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.